Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Estee Lauder
EL
|
$664M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$657M |
| 3 |
UnitedHealth
UNH
|
$644M |
| 4 |
AbbVie
ABBV
|
$544M |
| 5 |
PayPal
PYPL
|
$482M |
Top Sells
| 1 |
O'Reilly Automotive
ORLY
|
$559M |
| 2 |
SHPG
Shire pic
SHPG
|
$454M |
| 3 |
Amazon
AMZN
|
$448M |
| 4 |
Alibaba
BABA
|
$423M |
| 5 |
Ulta Beauty
ULTA
|
$412M |
Sector Composition
| 1 | Technology | 21.02% |
| 2 | Healthcare | 15.35% |
| 3 | Consumer Discretionary | 14.87% |
| 4 | Communication Services | 13.03% |
| 5 | Financials | 11.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Hess Midstream
HESM
$5.34B
| $5.21M | 0.01% |
237,273
+38,174
| +19% | +$839K |
|
502
iRhythm Technologies
IRTC
$5.82B
| $4.96M | 0.01% |
95,538
-203
| -0.2% | -$10.5K |
|
503
UroGen Pharma
URGN
$873M
| $4.68M | ﹤0.01% |
148,575
-26,835
| -15% | -$846K |
|
|
BWP
504
DELISTED
Boardwalk Pipeline Partners
BWP
| $4.65M | ﹤0.01% |
316,557
-505,002
| -61% | -$7.42M |
|
|
KA
505
DELISTED
Kineta, Inc. Common Stock
KA
| $4.35M | ﹤0.01% |
14,792
-33
| -0.2% | -$9.7K |
|
506
Enbridge
ENB
$105B
| $4.16M | ﹤0.01% |
99,656
-275,507
| -73% | -$11.5M |
|
507
SPDR S&P Metals & Mining ETF
XME
$2.35B
| $4.15M | ﹤0.01% |
128,847
+27,051
| +27% | +$870K |
|
508
IBM
IBM
$232B
| $3.37M | ﹤0.01% |
+24,295
| New | +$3.37M |
|
509
Westlake Corp
WLK
$11.5B
| $3.36M | ﹤0.01% |
+40,466
| New | +$3.36M |
|
|
RNTX
510
Rein Therapeutics, Inc. Common Stock
RNTX
$31M
| $3.34M | ﹤0.01% |
12,467
-33
| -0.3% | -$8.83K |
|
511
MacroGenics
MGNX
$126M
| $3.24M | ﹤0.01% |
175,225
-14,745
| -8% | -$272K |
|
|
NAK
512
Northern Dynasty Minerals
NAK
$466M
| $3.17M | ﹤0.01% |
1,763,422
| – | – |
|
513
First Bancorp
FBNC
$2.3B
| $3.12M | ﹤0.01% |
+90,788
| New | +$3.12M |
|
514
Tempest Therapeutics
TPST
$48.8M
| $3.11M | ﹤0.01% |
748
-1
| -0.1% | -$4.15K |
|
515
Johnson & Johnson
JNJ
$430B
| $2.82M | ﹤0.01% |
21,656
-5,094
| -19% | -$662K |
|
516
argenx
ARGX
$45.9B
| $2.8M | ﹤0.01% |
124,966
-319
| -0.3% | -$7.16K |
|
517
Rocket Pharmaceuticals
RCKT
$354M
| $2.77M | ﹤0.01% |
+389,179
| New | +$2.77M |
|
518
Northrop Grumman
NOC
$83.2B
| $2.64M | ﹤0.01% |
+9,172
| New | +$2.64M |
|
519
Micron Technology
MU
$147B
| $2.59M | ﹤0.01% |
+65,735
| New | +$2.59M |
|
520
iShares MSCI India ETF
INDA
$9.26B
| $2.48M | ﹤0.01% |
75,552
+8,733
| +13% | +$287K |
|
521
Altria Group
MO
$112B
| $2.45M | ﹤0.01% |
38,564
-323,873
| -89% | -$20.5M |
|
522
Verizon
VZ
$187B
| $2.31M | ﹤0.01% |
46,752
+16,306
| +54% | +$807K |
|
523
Waste Management
WM
$88.6B
| $2.27M | ﹤0.01% |
29,004
-17,042
| -37% | -$1.33M |
|
524
Yum! Brands
YUM
$40.1B
| $2.23M | ﹤0.01% |
+30,237
| New | +$2.23M |
|
525
Azenta
AZTA
$1.39B
| $2.2M | ﹤0.01% |
72,400
+14,727
| +26% | +$447K |
|